,pathway_id,pathway_type,pathway_class,pathway_name
0,N01394,Env factor,nt06252 Mitochondrial ROS formation.,KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV
1,N01401,Env factor,nt06251 CYP-mediated ROS formation.,KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM
2,N01352,Env factor,nt06210 ERK signaling.,KEGG_MEDICUS_ENV_FACTOR_BPA_TO_RAS_ERK_SIGNALING_PATHWAY
3,N01386,Env factor,nt06250 DNA adduct formation.,KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS
4,N01364,Env factor,nt06227 Nuclear receptor signaling.,KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY
5,N01353,Env factor,nt06210 ERK signaling.,KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY
6,N01414,Env factor,nt06460 Alzheimer disease.,KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT
7,N01407,Env factor,nt06211 Other MAPK signaling.,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY
8,N01413,Env factor,nt06226 KEAP1-NRF2 signaling.,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY
9,N01411,Env factor,nt06223 TNF signaling.,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY
10,N01408,Env factor,nt06210 ERK signaling.,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY
11,N01346,Env factor,nt06234 cAMP signaling.,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_CAMP_SIGNALING_PATHWAY
12,N01348,Env factor,nt06214 PI3K signaling.,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY
13,N01337,Env factor,nt06230 Cell cycle.,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY
14,N01339,Env factor,nt06214 PI3K signaling.,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339
15,N01350,Env factor,nt06214 PI3K signaling.,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350
16,N01344,Env factor,nt06210 ERK signaling.,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY
17,N01381,Env factor,nt06250 DNA adduct formation.,KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS
18,N01371,Env factor,nt06250 DNA adduct formation.,KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS
19,N01365,Env factor,nt06227 Nuclear receptor signaling.,KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY
20,N01403,Env factor,nt06460 Alzheimer disease.,KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT
21,N01392,Pathogen,nt06252 Mitochondrial ROS formation.,KEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II
22,N00478,Pathogen,nt06165 Epstein-Barr virus (EBV).,KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY
23,N00223,Pathogen,nt06165 Epstein-Barr virus (EBV).,KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION
24,N00225,Pathogen,nt06165 Epstein-Barr virus (EBV).,KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION
25,N00483,Pathogen,nt06165 Epstein-Barr virus (EBV).,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S
26,N00264,Pathogen,nt06165 Epstein-Barr virus (EBV).,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264
27,N00482,Pathogen,nt06165 Epstein-Barr virus (EBV).,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482
28,N00263,Pathogen,nt06165 Epstein-Barr virus (EBV).,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION
29,N00265,Pathogen,nt06516 TNF signaling.,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY
30,N01094,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY
31,N01092,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY
32,N01286,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY
33,N01086,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY
34,N01096,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY
35,N00544,Pathogen,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION
36,N00540,Pathogen,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY
37,N00547,Pathogen,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY
38,N00386,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY
39,N00394,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY
40,N00412,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY
41,N00407,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY
42,N00411,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAS_AC_PKA_SIGNALING_PATHWAY
43,N00409,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY
44,N00414,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY
45,N00406,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY
46,N00404,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAI_AC_PKA_SIGNALING_PATHWAY
47,N00402,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY
48,N00400,Pathogen,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY
49,N00518,Pathogen,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY
50,N00530,Pathogen,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_LXRA_MEDIATED_TRANSCRIPTION
51,N00431,Pathogen,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY
52,N00432,Pathogen,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN
53,N00434,Pathogen,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY
54,N00441,Pathogen,nt06516 TNF signaling.,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY
55,N00442,Pathogen,nt06516 TNF signaling.,KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY
56,N00449,Pathogen,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS
57,N00436,Pathogen,nt06517 TLR signaling.,KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY
58,N00447,Pathogen,nt06516 TNF signaling.,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY
59,N00456,Pathogen,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M
60,N00364,Pathogen,nt06166 Human papillomavirus (HPV).,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES
61,N00367,Pathogen,nt06166 Human papillomavirus (HPV).,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY
62,N00380,Pathogen,nt06511 NOTCH signaling.,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380
63,N00381,Pathogen,nt06511 NOTCH signaling.,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381
64,N00382,Pathogen,nt06511 NOTCH signaling.,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382
65,N00361,Pathogen,nt06166 Human papillomavirus (HPV).,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_CELL_CYCLE_G1_S
66,N00360,Pathogen,nt06166 Human papillomavirus (HPV).,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S
67,N00356,Pathogen,nt06530 PI3K signaling.,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_PP2A_AKT_SIGNALING_PATYWAY
68,N00560,Pathogen,nt06516 TNF signaling.,KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY
69,N00492,Pathogen,nt06229 MHC presentation.,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES
70,N00491,Pathogen,nt06518 JAK-STAT signaling.,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY
71,N00508,Pathogen,nt06160 Human T-cell leukemia virus 1 (HTLV-1).,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION
72,N00497,Pathogen,nt06160 Human T-cell leukemia virus 1 (HTLV-1).,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497
73,N00498,Pathogen,nt06160 Human T-cell leukemia virus 1 (HTLV-1).,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498
74,N00221,Pathogen,nt06230 Cell cycle.,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING
75,N00173,Pathogen,nt06516 TNF signaling.,KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY
76,N00175,Pathogen,nt06505 WNT signaling.,KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY
77,N00184,Pathogen,nt06229 MHC presentation.,KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES
78,N00185,Pathogen,nt06229 MHC presentation.,KEGG_MEDICUS_PATHOGEN_KSHV_MIR2_TO_CELL_SURFACE_MOLECULE_ENDOCYTOSIS
79,N00168,Pathogen,nt06230 Cell cycle.,KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S
80,N00171,Pathogen,nt06516 TNF signaling.,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY
81,N00174,Pathogen,nt06223 TNF signaling.,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY
82,N00157,Pathogen,nt06224 CXCR signaling.,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY
83,N00158,Pathogen,nt06224 CXCR signaling.,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY
84,N00178,Pathogen,nt06224 CXCR signaling.,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY
85,N01124,Pathogen,nt06505 WNT signaling.,KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY
86,N01298,Pathogen,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT
87,N01301,Pathogen,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES
88,N01305,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON
89,N01129,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY
90,N01130,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY
91,N01112,Pathogen,nt06521 NLR signaling.,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY
92,N01128,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY
93,N01318,Pathogen,nt06171 SARS coronavirus 2 (SARS-CoV-2).,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_NSP1_TO_TRANSLATION_INITIATION
94,N01316,Pathogen,nt06171 SARS coronavirus 2 (SARS-CoV-2).,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE
95,N01307,Pathogen,nt06171 SARS coronavirus 2 (SARS-CoV-2).,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY
96,N01314,Pathogen,nt06513 Complement cascade.,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE
97,N00950,Pathogen,nt06524 Apoptosis.,KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS
98,N01074,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY
99,N01081,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY
100,N01079,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY
101,N01067,Pathogen,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY
102,N01283,Pathogen,nt06517 TLR signaling.,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY
103,N00942,Pathogen,nt06516 TNF signaling.,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPG_TO_TNF_NFKB_SIGNALING_PATHWAY
104,N00862,Pathogen,nt06517 TLR signaling.,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY
105,N01029,Reference,nt06460 Alzheimer disease.,KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION
106,N01338,Reference,nt06214 PI3K signaling.,KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY
107,N01343,Reference,nt06210 ERK signaling.,KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY
108,N00297,Reference,nt06310 CRH-ACTH-cortisol signaling.,KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY
109,N01586,Reference,nt06523 Epigenetic regulation by Polycomb complexes.,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119
110,N01614,Reference,nt06523 Epigenetic regulation by Polycomb complexes.,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES
111,N01456,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY
112,N01688,Reference,nt06529 Thermogenesis.,KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY
113,N00994,Reference,nt06460 Alzheimer disease.,KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY
114,N00317,Reference,nt06227 Nuclear receptor signaling.,KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY
115,N01496,Reference,nt06513 Complement cascade.,KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN
116,N01454,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY
117,N01306,Reference,nt06171 SARS coronavirus 2 (SARS-CoV-2).,KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY
118,N00301,Reference,nt06316 Renin-angiotensin-aldosterone signaling.,KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY
119,N00978,Reference,nt06460 Alzheimer disease.,KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT
120,N00590,Reference,nt06168 Herpes simplex virus 1 (HSV-1).,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES
121,N00363,Reference,nt06229 MHC presentation.,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES
122,N00284,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY
123,N00279,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY
124,N01297,Reference,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT
125,N01066,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY
126,N01476,Reference,nt06510 Telomere length regulation.,KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE
127,N00499,Reference,nt06230 Cell cycle.,KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M
128,N01451,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_ATR_SIGNALING
129,N01721,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR
130,N01722,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55
131,N01719,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN
132,N00156,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION
133,N00155,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1
134,N01718,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2
135,N01715,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1
136,N01716,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR
137,N00915,Reference,nt06326 AVP signaling.,KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY
138,N01434,Reference,nt06504 Base excision repair.,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE
139,N01433,Reference,nt06504 Base excision repair.,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_MONOFUNCTIONAL_GLYCOSYLASE
140,N01435,Reference,nt06504 Base excision repair.,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE
141,N01695,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY
142,N00487,Reference,nt06220 Calcium signaling.,KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY
143,N01463,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY
144,N00804,Reference,nt06020 beta-Oxidation in mitochondria.,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION
145,N00765,Reference,nt06020 beta-Oxidation in mitochondria.,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS
146,N00805,Reference,nt06022 Bile acid biosynthesis.,KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS
147,N01620,Reference,nt06523 Epigenetic regulation by Polycomb complexes.,KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2
148,N01651,Reference,nt06035 Blood group carbohydrate antigen biosynthesis.,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_1_BIOSYNTHESIS
149,N01666,Reference,nt06035 Blood group carbohydrate antigen biosynthesis.,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS
150,N01455,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY
151,N01426,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY
152,N01458,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY
153,N01461,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY_AUXILIARY_FACTOR
154,N01453,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY
155,N01428,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST
156,N01549,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION
157,N01450,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION
158,N01142,Reference,nt06532 Autophagy.,KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION
159,N01648,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY
160,N01647,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY
161,N01649,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY
162,N01642,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL
163,N01637,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL
164,N01655,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY
165,N00538,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY
166,N01639,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING
167,N00291,Reference,nt06318 CaSR-PTH signaling.,KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY
168,N00399,Reference,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY
169,N00428,Reference,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY
170,N00153,Reference,nt06224 CXCR signaling.,KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY
171,N00505,Reference,nt06516 TNF signaling.,KEGG_MEDICUS_REFERENCE_CD40_NFKB_SIGNALING_PATHWAY
172,N00683,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY
173,N01579,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY
174,N00455,Reference,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M
175,N01531,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX
176,N00395,Reference,nt06520 CGAS-STING signaling.,KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY
177,N01624,Reference,nt06034 Cholesterol biosynthesis.,KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS
178,N01580,Reference,nt06029 Glycosaminoglycan biosynthesis.,KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS
179,N01336,Reference,nt06230 Cell cycle.,KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY
180,N01604,Reference,nt06031 Citrate cycle and pyruvate metabolism.,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION
181,N01617,Reference,nt06031 Citrate cycle and pyruvate metabolism.,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2
182,N01487,Reference,nt06513 Complement cascade.,KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION
183,N01486,Reference,nt06512 Chromosome cohesion and segregation.,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE
184,N01485,Reference,nt06512 Chromosome cohesion and segregation.,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE
185,N01482,Reference,nt06512 Chromosome cohesion and segregation.,KEGG_MEDICUS_REFERENCE_COHESIN_LOADING
186,N01490,Reference,nt06513 Complement cascade.,KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION
187,N01497,Reference,nt06512 Chromosome cohesion and segregation.,KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING
188,N01289,Reference,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION
189,N01293,Reference,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION
190,N01431,Reference,nt06502 Nucleotide excision repair.,KEGG_MEDICUS_REFERENCE_CORE_NER_REACTION
191,N01612,Reference,"nt06033 Glycine,serine and arginine metabolism.",KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY
192,N00324,Reference,nt06310 CRH-ACTH-cortisol signaling.,KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY
193,N00146,Reference,nt06524 Apoptosis.,KEGG_MEDICUS_REFERENCE_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS
194,N00403,Reference,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY
195,N00546,Reference,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY
196,N00405,Reference,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY
197,N00430,Reference,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY
198,N00401,Reference,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY
199,N00413,Reference,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY
200,N00433,Reference,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY
201,N00152,Reference,nt06224 CXCR signaling.,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY
202,N00154,Reference,nt06224 CXCR signaling.,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY
203,N00053,Reference,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY
204,N01536,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE
205,N00610,Reference,nt06012 Glycosaminoglycan degradation.,KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION
206,N01585,Reference,nt06523 Epigenetic regulation by Polycomb complexes.,KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119
207,N01533,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC
208,N01571,Reference,nt06520 CGAS-STING signaling.,KEGG_MEDICUS_REFERENCE_DNA_DEGRADATION_BY_EXTRACELLULAR_ENDOLYSOSOMAL_DNASE
209,N01446,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING
210,N01468,Reference,nt06509 DNA replication.,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING
211,N01473,Reference,nt06509 DNA replication.,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION
212,N01448,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION
213,N01439,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING
214,N00410,Reference,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY
215,N01534,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE
216,N01351,Reference,nt06210 ERK signaling.,KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY
217,N01302,Reference,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION
218,N01078,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY
219,N00390,Reference,nt06214 PI3K signaling.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY
220,N00033,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY
221,N00147,Reference,nt06220 Calcium signaling.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY
222,N00026,Reference,nt06273 Glioma.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY
223,N00023,Reference,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY
224,N00001,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY
225,N00542,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY
226,N00030,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY
227,N00103,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY
228,N00096,Reference,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY
229,N00021,Reference,nt06261 Gastric cancer.,KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY
230,N00094,Reference,nt06262 Pancreatic cancer.,KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY
231,N00995,Reference,nt06460 Alzheimer disease.,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I
232,N00990,Reference,nt06252 Mitochondrial ROS formation.,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III
233,N00998,Reference,nt06252 Mitochondrial ROS formation.,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV
234,N01345,Reference,nt06234 cAMP signaling.,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY
235,N01347,Reference,nt06214 PI3K signaling.,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_PI3K_SIGNALING_PATHWAY
236,N00282,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY
237,N00277,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY
238,N01601,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING
239,N01484,Reference,nt06512 Chromosome cohesion and segregation.,KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION
240,N00145,Reference,nt06516 TNF signaling.,KEGG_MEDICUS_REFERENCE_EXTRINSIC_APOPTOTIC_PATHWAY
241,N01464,Reference,nt06508 Interstrand crosslink repair.,KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY
242,N01056,Reference,nt06524 Apoptosis.,KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY
243,N01587,Reference,nt06525 Ferroptosis.,KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT
244,N00037,Reference,nt06261 Gastric cancer.,KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY
245,N00019,Reference,nt06261 Gastric cancer.,KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY
246,N01584,Reference,nt06522 mTOR signaling.,KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY
247,N00217,Reference,nt06275 Acute myeloid leukemia.,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY
248,N00218,Reference,nt06262 Pancreatic cancer.,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY
249,N00922,Reference,nt06323 KISS1-GnRH-LH/FSH-E2 signaling.,KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY
250,N01578,Reference,nt06522 mTOR signaling.,KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY
251,N01577,Reference,nt06523 Epigenetic regulation by Polycomb complexes.,KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119
252,N01656,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY
253,N01592,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY
254,N01658,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY
255,N00910,Reference,nt06324 GHRH-GH-IGF signaling.,KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY
256,N00907,Reference,nt06324 GHRH-GH-IGF signaling.,KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY
257,N01425,Reference,nt06502 Nucleotide excision repair.,KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER
258,N01605,Reference,nt06031 Citrate cycle and pyruvate metabolism.,KEGG_MEDICUS_REFERENCE_GLUCONEOGENESIS
259,N01589,Reference,nt06026 Glutathione biosynthesis.,KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS
260,N00713,Reference,nt06017 Glycogen metabolism.,KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS
261,N00718,Reference,nt06017 Glycogen metabolism.,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION
262,N00720,Reference,nt06017 Glycogen metabolism.,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_
263,N00731,Reference,nt06017 Glycogen metabolism.,KEGG_MEDICUS_REFERENCE_GLYCOLYSIS
264,N01574,Reference,nt06029 Glycosaminoglycan biosynthesis.,KEGG_MEDICUS_REFERENCE_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE
265,N00873,Reference,nt06323 KISS1-GnRH-LH/FSH-E2 signaling.,KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY
266,N01657,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY
267,N01640,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY
268,N00748,Reference,nt06018 GPI-anchor biosynthesis.,KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS
269,N00062,Reference,nt06501 HH signaling.,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY
270,N01537,Reference,nt06501 HH signaling.,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION
271,N01538,Reference,nt06501 HH signaling.,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR
272,N00601,Reference,nt06011 Heme biosynthesis.,KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS
273,N01582,Reference,nt06029 Glycosaminoglycan biosynthesis.,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS
274,N00615,Reference,nt06012 Glycosaminoglycan degradation.,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION
275,N00043,Reference,nt06261 Gastric cancer.,KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY
276,N00216,Reference,nt06261 Gastric cancer.,KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY
277,N00079,Reference,nt06264 Renal cell carcinoma.,KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY
278,N01452,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION
279,N01466,Reference,nt06508 Interstrand crosslink repair.,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR
280,N01555,Reference,nt06518 JAK-STAT signaling.,KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY
281,N00649,Reference,nt06014 Sphingolipid degradation.,KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN
282,N01696,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY
283,N01662,Reference,nt06527 Necroptosis.,KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY
284,N00234,Reference,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY
285,N00582,Reference,nt06168 Herpes simplex virus 1 (HSV-1).,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY
286,N00233,Reference,nt06324 GHRH-GH-IGF signaling.,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY
287,N00182,Reference,nt06214 PI3K signaling.,KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY
288,N01090,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY
289,N01678,Reference,nt06035 Blood group carbohydrate antigen biosynthesis.,KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS
290,N00415,Reference,nt06518 JAK-STAT signaling.,KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY
291,N01557,Reference,nt06518 JAK-STAT signaling.,KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY
292,N00188,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY
293,N00186,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY
294,N01554,Reference,nt06518 JAK-STAT signaling.,KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY
295,N01556,Reference,nt06518 JAK-STAT signaling.,KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY
296,N01501,Reference,nt06512 Chromosome cohesion and segregation.,KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I
297,N00098,Reference,nt06524 Apoptosis.,KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY
298,N01013,Reference,nt06534 Unfolded protein response.,KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY
299,N00856,Reference,"nt06024 Valine,leucine and isoleucine degradation.",KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION
300,N01070,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY
301,N01068,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY
302,N00393,Reference,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY
303,N01072,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY
304,N00951,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY
305,N01080,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY
306,N00243,Reference,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY
307,N00623,Reference,nt06012 Glycosaminoglycan degradation.,KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION
308,N01547,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION
309,N01535,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT
310,N00869,Reference,nt06323 KISS1-GnRH-LH/FSH-E2 signaling.,KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY
311,N00045,Reference,nt06275 Acute myeloid leukemia.,KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY
312,N00215,Reference,nt06275 Acute myeloid leukemia.,KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY
313,N01502,Reference,nt06171 SARS coronavirus 2 (SARS-CoV-2).,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN
314,N01315,Reference,nt06171 SARS coronavirus 2 (SARS-CoV-2).,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN
315,N01491,Reference,nt06513 Complement cascade.,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION
316,N01465,Reference,nt06508 Interstrand crosslink repair.,KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION
317,N00851,Reference,"nt06024 Valine,leucine and isoleucine degradation.",KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION
318,N01672,Reference,nt06035 Blood group carbohydrate antigen biosynthesis.,KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS
319,N00885,Reference,nt06323 KISS1-GnRH-LH/FSH-E2 signaling.,KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY
320,N00559,Reference,nt06516 TNF signaling.,KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY
321,N01636,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX
322,N01436,Reference,nt06504 Base excision repair.,KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER
323,N00408,Reference,nt06167 Human cytomegalovirus (HCMV).,KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY
324,N01097,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY
325,N01104,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY
326,N01644,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE
327,N01000,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY
328,N00342,Reference,nt06166 Human papillomavirus (HPV).,KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY
329,N00699,Reference,nt06013 O-Glycan biosynthesis.,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE
330,N00627,Reference,nt06013 O-Glycan biosynthesis.,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK
331,N01308,Reference,nt06519 RLR signaling.,KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY
332,N00066,Reference,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066
333,N00536,Reference,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536
334,N01356,Reference,nt06214 PI3K signaling.,KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY
335,N01607,Reference,nt06030 Methionine metabolism.,KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION
336,N01635,Reference,nt06034 Cholesterol biosynthesis.,KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY
337,N00953,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY
338,N00984,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY
339,N01561,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION
340,N01562,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS
341,N01544,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION
342,N01285,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY
343,N01432,Reference,nt06503 Mismatch repair.,KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR
344,N01691,Reference,nt06529 Thermogenesis.,KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS
345,N01594,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY
346,N01499,Reference,nt06512 Chromosome cohesion and segregation.,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_II_SUBUNITS
347,N01457,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY
348,N01723,Reference,nt06036 Lysine degradation.,KEGG_MEDICUS_REFERENCE_NAD_BIOSYNTHESIS
349,N00742,Reference,nt06521 NLR signaling.,KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY
350,N01459,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY
351,N00940,Reference,nt06521 NLR signaling.,KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY
352,N00934,Reference,nt06521 NLR signaling.,KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY
353,N01445,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING
354,N01479,Reference,nt06511 NOTCH signaling.,KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION
355,N01481,Reference,nt06511 NOTCH signaling.,KEGG_MEDICUS_REFERENCE_NOTCH_MESP2_SIGNALING
356,N01478,Reference,nt06511 NOTCH signaling.,KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION
357,N00086,Reference,nt06511 NOTCH signaling.,KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY
358,N01163,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY
359,N01152,Reference,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA
360,N00286,Reference,nt06323 KISS1-GnRH-LH/FSH-E2 signaling.,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY
361,N00820,Reference,nt06015 N-Glycan biosynthesis.,KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS
362,N00681,Reference,nt06015 N-Glycan biosynthesis.,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST
363,N00653,Reference,nt06015 N-Glycan biosynthesis.,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG7_TO_ALG11
364,N00667,Reference,nt06015 N-Glycan biosynthesis.,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL
365,N01472,Reference,nt06509 DNA replication.,KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION
366,N01525,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_INNER_KINETOCHORE
367,N01526,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE
368,N01471,Reference,nt06509 DNA replication.,KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION
369,N00069,Reference,nt06262 Pancreatic cancer.,KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S
370,N00091,Reference,nt06261 Gastric cancer.,KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S
371,N00347,Reference,nt06166 Human papillomavirus (HPV).,KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S
372,N01358,Reference,nt06214 PI3K signaling.,KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY
373,N01360,Reference,nt06210 ERK signaling.,KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY
374,N00039,Reference,nt06273 Glioma.,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY
375,N00028,Reference,nt06273 Glioma.,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY
376,N00015,Reference,nt06273 Glioma.,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY
377,N01165,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY
378,N01137,Reference,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION
379,N01542,Reference,nt06310 CRH-ACTH-cortisol signaling.,KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME
380,N00571,Reference,nt06170 Influenza A virus (IAV).,KEGG_MEDICUS_REFERENCE_PKR_EIF2ALPHA_SIGNALING_PATHWAY
381,N01460,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA
382,N00355,Reference,nt06530 PI3K signaling.,KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY
383,N01470,Reference,nt06509 DNA replication.,KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION
384,N01204,Reference,nt06465 Prion disease.,KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY
385,N00879,Reference,nt06361 Hypogonadotropic hypogonadism.,KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY
386,N01553,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH
387,N00288,Reference,nt06318 CaSR-PTH signaling.,KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY
388,N01418,Reference,nt06027 Purine salvage pathway.,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP
389,N01421,Reference,nt06027 Purine salvage pathway.,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP
390,N01295,Reference,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT
391,N01119,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY
392,N01539,Reference,nt06508 Interstrand crosslink repair.,KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION
393,N01529,Reference,nt06515 Regulation of kinetochore-microtubule interactions.,KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC
394,N01504,Reference,nt06513 Complement cascade.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR
395,N01505,Reference,nt06513 Complement cascade.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION
396,N01520,Reference,nt06513 Complement cascade.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH
397,N01524,Reference,nt06514 Coagulation cascade.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI
398,N01598,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE
399,N01595,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS
400,N01593,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP
401,N01600,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP
402,N01596,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX
403,N01597,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1
404,N01599,Reference,nt06526 MAPK signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL
405,N01646,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA
406,N01545,Reference,nt06516 TNF signaling.,KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION
407,N00963,Reference,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY
408,N01743,Reference,nt06316 Renin-angiotensin-aldosterone signaling.,KEGG_MEDICUS_REFERENCE_RENIN_ANGIOTENSIN_SIGNALING_PATHWAY
409,N00976,Reference,nt06463 Parkinson disease.,KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT
410,N00469,Reference,nt06519 RLR signaling.,KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY
411,N00688,Reference,nt06519 RLR signaling.,KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY
412,N01641,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY
413,N01551,Reference,nt06028 Dopamine and serotonin metabolism.,KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM
414,N01674,Reference,nt06035 Blood group carbohydrate antigen biosynthesis.,KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS
415,N01638,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING
416,N00493,Reference,nt06230 Cell cycle.,KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING
417,N00338,Reference,nt06019 Steroid hormone biosynthesis.,KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE
418,N01576,Reference,nt06522 mTOR signaling.,KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY
419,N00882,Reference,nt06323 KISS1-GnRH-LH/FSH-E2 signaling.,KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY
420,N01140,Reference,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION
421,N01106,Reference,nt06528 Calcium signaling.,KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY
422,N01477,Reference,nt06510 Telomere length regulation.,KEGG_MEDICUS_REFERENCE_TELOMERE_ELONGATION
423,N01541,Reference,nt06019 Steroid hormone biosynthesis.,KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS
424,N01300,Reference,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES
425,N00231,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY
426,N00227,Reference,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY
427,N00229,Reference,nt06260 Colorectal cancer.,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY
428,N00063,Reference,nt06507 TGFB signaling.,KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY
429,N00798,Reference,nt06322 TRH-TSH-TH signaling.,KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY
430,N01287,Reference,nt06135 Cytoskeletal regulation (viruses and bacteria).,KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY
431,N00435,Reference,nt06517 TLR signaling.,KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY
432,N00438,Reference,nt06517 TLR signaling.,KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY
433,N00149,Reference,nt06517 TLR signaling.,KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY
434,N00148,Reference,nt06517 TLR signaling.,KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY
435,N00563,Reference,nt06168 Herpes simplex virus 1 (HSV-1).,KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY
436,N00553,Reference,nt06517 TLR signaling.,KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY
437,N01566,Reference,nt06517 TLR signaling.,KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY
438,N01543,Reference,nt06517 TLR signaling.,KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY
439,N00690,Reference,nt06517 TLR signaling.,KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY
440,N00446,Reference,nt06516 TNF signaling.,KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY
441,N00151,Reference,nt06516 TNF signaling.,KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY
442,N00444,Reference,nt06516 TNF signaling.,KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY
443,N01621,Reference,nt06527 Necroptosis.,KEGG_MEDICUS_REFERENCE_TNF_RIPK1_3_SIGNALING_PATHWAY
444,N01474,Reference,nt06509 DNA replication.,KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY
445,N01701,Reference,nt06523 Epigenetic regulation by Polycomb complexes.,KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27
446,N01430,Reference,nt06502 Nucleotide excision repair.,KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER
447,N01317,Reference,nt06171 SARS coronavirus 2 (SARS-CoV-2).,KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION
448,N00970,Reference,nt06460 Alzheimer disease.,KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM
449,N01291,Reference,nt06125 Membrane trafficking (bacteria).,KEGG_MEDICUS_REFERENCE_TRAPPI_RAB1_SIGNALING_PATHWAY
450,N00918,Reference,nt06322 TRH-TSH-TH signaling.,KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY
451,N01575,Reference,nt06522 mTOR signaling.,KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY
452,N00793,Reference,nt06322 TRH-TSH-TH signaling.,KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY
453,N00782,Reference,nt06322 TRH-TSH-TH signaling.,KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY
454,N01559,Reference,nt06518 JAK-STAT signaling.,KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY
455,N00150,Reference,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY
456,N01558,Reference,nt06518 JAK-STAT signaling.,KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY
457,N00708,Reference,nt06016 Phenylalanine and tyrosine metabolism.,KEGG_MEDICUS_REFERENCE_TYROSINE_DEGRADATION
458,N00593,Reference,nt06010 Urea cycle.,KEGG_MEDICUS_REFERENCE_UREA_CYCLE
459,N00852,Reference,"nt06024 Valine,leucine and isoleucine degradation.",KEGG_MEDICUS_REFERENCE_VALINE_DEGRADATION
460,N00967,Reference,nt06460 Alzheimer disease.,KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY
461,N01467,Reference,nt06506 Double-strand break repair.,KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION
462,N00459,Reference,nt06161 Human immunodeficiency virus 1 (HIV-1).,KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M
463,N01427,Reference,nt06505 WNT signaling.,KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY
464,N01440,Reference,nt06505 WNT signaling.,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO
465,N01441,Reference,nt06505 WNT signaling.,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4
466,N01443,Reference,nt06505 WNT signaling.,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION
467,N01442,Reference,nt06505 WNT signaling.,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR
468,N00056,Reference,nt06505 WNT signaling.,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY
469,N00275,Variant,nt06270 Breast cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCND1_TO_CELL_CYCLE_G1_S
470,N00255,Variant,nt06261 Gastric cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S
471,N00072,Variant,nt06273 Glioma.,KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S
472,N00035,Variant,nt06273 Glioma.,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY
473,N00027,Variant,nt06273 Glioma.,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY
474,N00006,Variant,nt06265 Bladder cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY
475,N00038,Variant,nt06261 Gastric cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY
476,N00020,Variant,nt06261 Gastric cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY
477,N00068,Variant,nt06273 Glioma.,KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S
478,N00260,Variant,nt06261 Gastric cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY
479,N00131,Variant,nt06240 Transcription.,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION
480,N00132,Variant,nt06240 Transcription.,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_REPRESSION
481,N00089,Variant,nt06267 Small cell lung cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S
482,N00088,Variant,nt06267 Small cell lung cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P15_CELL_CYCLE_G1_S
483,N00092,Variant,nt06267 Small cell lung cancer.,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S
484,N00040,Variant,nt06273 Glioma.,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY
485,N00029,Variant,nt06273 Glioma.,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY
486,N00018,Variant,nt06273 Glioma.,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY
487,N00123,Variant,nt06240 Transcription.,KEGG_MEDICUS_VARIANT_AMPLIFIED_REL_TO_TRANSCRIPTION
488,N00285,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_AREG_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY
489,N00100,Variant,nt06267 Small cell lung cancer.,KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY
490,N00048,Variant,nt06276 Chronic myeloid leukemia.,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY
491,N00002,Variant,nt06276 Chronic myeloid leukemia.,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY
492,N00061,Variant,nt06274 Thyroid cancer.,KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY
493,N00298,Variant,nt06310 CRH-ACTH-cortisol signaling.,KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY
494,N00964,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_DAB1_OVEREXPRESSION_TO_RELN_VLDLR_PI3K_SIGNALING_PATHWAY
495,N00465,Variant,.,KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX
496,N00004,Variant,nt06275 Acute myeloid leukemia.,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY
497,N00031,Variant,nt06275 Acute myeloid leukemia.,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY
498,N00042,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY
499,N00281,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY
500,N00276,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY
501,N00047,Variant,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY
502,N00025,Variant,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY
503,N00007,Variant,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY
504,N00095,Variant,nt06262 Pancreatic cancer.,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY
505,N00034,Variant,nt06262 Pancreatic cancer.,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY
506,N00283,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_EREG_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY
507,N00137,Variant,nt06240 Transcription.,KEGG_MEDICUS_VARIANT_EWSR1_WT1_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION
508,N00059,Variant,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY
509,N00077,Variant,nt06265 Bladder cancer.,KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY
510,N00235,Variant,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY
511,N00125,Variant,nt06240 Transcription.,KEGG_MEDICUS_VARIANT_IGH_MMSET_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION
512,N00093,Variant,nt06272 Prostate cancer.,KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S
513,N00097,Variant,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY
514,N00080,Variant,nt06264 Renal cell carcinoma.,KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY
515,N00060,Variant,nt06270 Breast cancer.,KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY
516,N00248,Variant,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY
517,N00119,Variant,nt06240 Transcription.,KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION
518,N00120,Variant,nt06240 Transcription.,KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION
519,N00302,Variant,nt06316 Renin-angiotensin-aldosterone signaling.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY
520,N00036,Variant,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY
521,N00024,Variant,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY
522,N00014,Variant,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY
523,N00011,Variant,nt06265 Bladder cancer.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY
524,N00321,Variant,nt06360 Cushing syndrome.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY
525,N00326,Variant,nt06360 Cushing syndrome.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY
526,N00954,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GRM1_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY
527,N00958,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_ITPR1_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY
528,N00303,Variant,nt06316 Renin-angiotensin-aldosterone signaling.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY
529,N00046,Variant,nt06275 Acute myeloid leukemia.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY
530,N00003,Variant,nt06275 Acute myeloid leukemia.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY
531,N00012,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY
532,N00032,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY
533,N00044,Variant,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY
534,N00005,Variant,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY
535,N00049,Variant,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY
536,N00320,Variant,nt06360 Cushing syndrome.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY
537,N01065,Variant,nt06214 PI3K signaling.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY
538,N00017,Variant,nt06269 Basal cell carcinoma.,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY
539,N00957,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY
540,N01060,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION
541,N00996,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY
542,N01018,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT
543,N01005,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS
544,N00997,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I
545,N00999,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV
546,N01014,Variant,nt06534 Unfolded protein response.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY
547,N01001,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY
548,N01002,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY
549,N01003,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM
550,N01004,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004
551,N01006,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006
552,N00966,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION
553,N01158,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT
554,N01061,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION
555,N00979,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT
556,N00993,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION
557,N00981,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION
558,N00991,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III
559,N00985,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY
560,N00980,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION
561,N00977,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT
562,N00992,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY
563,N00987,Variant,nt06461 Huntington disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM
564,N00971,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM
565,N01017,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT
566,N01008,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY
567,N01007,Variant,nt06460 Alzheimer disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY
568,N01030,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION
569,N01055,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT
570,N01042,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I
571,N01035,Variant,nt06534 Unfolded protein response.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_PERK_ATF4_SIGNALING_PATHWAY
572,N01031,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY
573,N01144,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION
574,N01135,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY
575,N01149,Variant,nt06534 Unfolded protein response.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_PERK_ATF4_SIGNALING_PATHWAY
576,N01160,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT
577,N00960,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY
578,N01136,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I
579,N01159,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TUBA4A_TO_RETROGRADE_AXONAL_TRANSPORT
580,N00057,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY
581,N00304,Variant,nt06316 Renin-angiotensin-aldosterone signaling.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY
582,N00305,Variant,nt06316 Renin-angiotensin-aldosterone signaling.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY
583,N00962,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATXN3_TO_AUTOPHAGY_VESICLE_NUCLEATION
584,N00242,Variant,nt06263 Hepatocellular carcinoma.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY
585,N01057,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY
586,N00877,Variant,nt06361 Hypogonadotropic hypogonadism.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY
587,N00876,Variant,nt06361 Hypogonadotropic hypogonadism.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF8_TO_RAS_ERK_SIGNALING_PATHWAY
588,N01138,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_OPTN_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION
589,N01139,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION
590,N00323,Variant,nt06310 CRH-ACTH-cortisol signaling.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY
591,N01043,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I
592,N01048,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048
593,N01050,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050
594,N00322,Variant,nt06360 Cushing syndrome.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY
595,N00327,Variant,nt06360 Cushing syndrome.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY
596,N00955,Variant,nt06462 Spinocerebellar ataxia.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY
597,N01049,Variant,nt06463 Parkinson disease.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY
598,N00880,Variant,nt06361 Hypogonadotropic hypogonadism.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY
599,N00881,Variant,nt06361 Hypogonadotropic hypogonadism.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY
600,N00010,Variant,nt06269 Basal cell carcinoma.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY
601,N00325,Variant,nt06310 CRH-ACTH-cortisol signaling.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY
602,N01151,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY
603,N00115,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION
604,N01146,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION
605,N01145,Variant,nt06464 Amyotrophic lateral sclerosis.,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION
606,N00087,Variant,nt06270 Breast cancer.,KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY
607,N01202,Variant,nt06465 Prion disease.,KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT
608,N00008,Variant,nt06266 Non-small cell lung cancer.,KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY
609,N01197,Variant,nt06465 Prion disease.,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION
610,N01199,Variant,nt06465 Prion disease.,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY
611,N01198,Variant,nt06534 Unfolded protein response.,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY
612,N01205,Variant,nt06465 Prion disease.,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PRNP_PI3K_NOX2_SIGNALING_PATHWAY
613,N01200,Variant,nt06465 Prion disease.,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM
614,N01201,Variant,nt06465 Prion disease.,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY
615,N00118,Variant,nt06240 Transcription.,KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION
616,N00232,Variant,nt06260 Colorectal cancer.,KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY
617,N00128,Variant,nt06272 Prostate cancer.,KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION
618,N00009,Variant,nt06274 Thyroid cancer.,KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY
